nad has been researched along with Polyarthritis in 4 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 1 (25.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 1 (25.00) | 29.6817 |
2010's | 2 (50.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Bogaczewicz, J; Tokarska, K; Wozniacka, A | 1 |
Caimano, MJ; Claiborne, A; Cusack, B; Desrosiers, DC; Eggers, CH; Hazlett, KR; Kariu, T; Malizia, RA; Pal, U; Radolf, JD | 1 |
Auscher, C; Brouilhet, H; Rabaud, M; Van der Kemp, P | 1 |
Abdelkarim, GE; Getting, SJ; Haskó, G; Jagtap, P; Liaudet, L; Mabley, JG; Marton, A; Perretti, M; Salzman, AL; Soriano, FG; Southan, GJ; Szabó, C; Szabó, E; Virág, L | 1 |
4 other study(ies) available for nad and Polyarthritis
Article | Year |
---|---|
Changes of NADH Fluorescence from the Skin of Patients with Systemic Lupus Erythematosus.
Topics: Adult; Aged; Aged, 80 and over; Arthritis; Autoimmune Diseases; Case-Control Studies; Female; Fluorescence; Humans; Lupus Erythematosus, Systemic; Male; Microcirculation; Middle Aged; NAD; Skin; Young Adult | 2019 |
The coenzyme A disulphide reductase of Borrelia burgdorferi is important for rapid growth throughout the enzootic cycle and essential for infection of the mammalian host.
Topics: Aerobiosis; Amino Acid Sequence; Anaerobiosis; Animals; Anti-Bacterial Agents; Arthritis; Borrelia burgdorferi; Borrelia Infections; Coenzyme A; Gene Deletion; Gene Expression Regulation, Bacterial; Genetic Complementation Test; Ixodes; Mice; Models, Molecular; Molecular Sequence Data; NAD; NADH, NADPH Oxidoreductases; Nymph; Oxidants; Sequence Homology; Survival Analysis; Transcription, Genetic; Virulence; Virulence Factors | 2011 |
[Xanthine oxidase activity: O2-dependent and NAD+-dependent forms in the liver, in rats with adjuvant arthritis and hepatitis].
Topics: Aerobiosis; Animals; Arthritis; Arthritis, Experimental; Cytosol; Disease Models, Animal; Hepatitis; Liver; Male; NAD; Oxygen; Rats; Rats, Inbred Strains; Xanthine Oxidase | 1983 |
Anti-inflammatory effects of a novel, potent inhibitor of poly (ADP-ribose) polymerase.
Topics: Adenosine Triphosphate; Animals; Anti-Inflammatory Agents; Arthritis; Colitis; Collagen; Diabetes Mellitus, Experimental; Dose-Response Relationship, Drug; Endotoxemia; Enzyme Inhibitors; Male; Mice; Mice, Inbred DBA; NAD; Peritonitis; Phenanthrenes; Poly(ADP-ribose) Polymerase Inhibitors; Uveitis | 2001 |